| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |